Navigation Links
Ascension Orthopedics Granted Patent for PyroCarbon Humeral Head Design
Date:1/10/2011

AUSTIN, Texas, Jan. 10, 2011 /PRNewswire/ -- Ascension Orthopedics, Inc., a market leader in PyroCarbon orthopedic implants, announces the receipt of a European patent for a PyroCarbon humeral head design currently being developed as a component of the TITAN™ Modular Shoulder System released in September 2010.

Jerome Klawitter, Ph.D., Founder and Chief Science Officer of Ascension Orthopedics, commented, "I am very pleased our PyroCarbon humeral head hemi-arthroplasty has been patented. PyroCarbon has been shown to cause much less damage to cartilage and bone joint tissues than the Co-Cr metal alloy currently used for shoulder joint hemi-arthroplasty. A PyroCarbon humeral head replacement should extend the functional life of shoulder hemi-arthroplasty and result in improved patient outcomes.  Extensive design and testing has resulted in the development of a product which will soon be available for clinical use."

Klawitter pioneered efforts using PyroCarbon in the manufacture of mechanical heart valves. In the 1970's, his focus turned toward the design of PyroCarbon implants for the orthopedic market. His collaborative efforts with the Mayo Clinic lead to the founding of Ascension Orthopedics in 1992. Since the introduction in 2000 of the first PyroCarbon total joint replacement for the MCP joint of the hand, Ascension has been dedicated to building on the company's experience by successfully using PyroCarbon in both hemi and total joint arthroplasty applications."Our commitment to research with PyroCarbon is based on the material's enhanced wear resistance and biocompatibility against native bone and cartilage compared to metals and ceramics. Native joints have been shown to lubricate through the adsorption of surfactant to cartilage, providing boundary layer lubrication. Similarly, adsorption of surfactant onto graphitic surfaces aids in lubricating joints, offering favorable wear characteristics against native cartilage," added Klawitter.

Ascension Orthopedics is the world leader in PyroCarbon arthroplasty with over 35,000 PyroCarbon extremity joints implanted. Marketed devices include PyroCarbon implants for the hand, wrist, elbow, shoulder and foot. The company is continuing its research and development for the shoulder, with several new products launching in 2011. Ascension's mission is to transform extremities by developing state-of-the-art orthopedic products for the upper and lower limbs to help patients suffering from pain and dysfunction. Ascension Orthopedics sells products in the United States and more than 20 countries worldwide. For further information, please visit http://www.ascensionortho.com/.FOR INFORMATION CONTACT:Laura LatimerAscension Orthopedics, Inc.512-836-5001
'/>"/>

SOURCE Ascension Orthopedics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ascension Orthopedics Implants PyroTITAN™ in France
2. Ascension Orthopedics Announces Implantation of the TITAN™ Modular Total Shoulder
3. Ascension Orthopedics Announces First Implantations of TITAN™ Modular Shoulder
4. Ascension Orthopedics Receives FDA Approval for TITAN™ Modular Total Shoulder System
5. Ascension Orthopedics Implants First PyroCarbon Shoulder Device in United Kingdom
6. Phreesia to Accelerate Growth with $16 Million Investment Led by Ascension Health Ventures
7. Ascension Orthopedics Hires Key Senior Executives
8. Orthopedics This Week Announces 2010 Best Spine Technology Award Winners
9. Two Amedica®/US Spine® Implant Products Receive Best New Technology Awards from Orthopedics This Week
10. Trinity Orthopedics Receives Patent Allowance for Sagittally Stable Spinal Fixation System
11. ICAP Ocean Tomo Offers for Sale IP Portfolio of Active Implants for Electromagnetic Bone and Tissue Regeneration in Orthopedics, Trauma, and Wound Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, Sympathomimetic-GABA ... drugs market is expected to grow at a CAGR of ... of 38.7% in the second half of the forecast period. The ... 2016 to 2027. The market is estimated at $1,058 million in ... ...
(Date:1/19/2017)... -- James Gilbart , ... 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ...      ... in a supplement to European Oncology & Haematology ... by James Gilbart and Axel ...
(Date:1/19/2017)... , Jan. 19, 2017   Science Exchange , ... to announce that the first five replication studies ... have been published in eLife today. Despite intense ... the first practical evaluation of reproducibility rates that ... studies. Unlike other assessments of reproducibility, the results ...
Breaking Medicine Technology:
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... ... wellness products to enhance people’s everyday lives, recently attended the January ECRM Trade ... , ATP Science is known for its large range of supplements that keep ...
(Date:1/20/2017)... ... ... Michael and Betsy Brauser celebrated 5 years of Betsy’s participation in a ... has been life-saving as she has been on the trial for more than six ... ovarian cancer in 2009. She underwent standard chemotherapy but a year later went to ...
(Date:1/20/2017)... ... 20, 2017 , ... Vitamin Well has launched two new ... have been produced in collaboration with Zlatan Ibrahimovic and have been developed to ... a successful launch in Sweden last year, the next generation sports drinks VW+001 ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... “The Angel”: ... the Lord has set out for each of his children. “The Angel” is the ... School of Music in New York City, and impassioned writer. , When asked of ...
(Date:1/20/2017)... ... ... fine examination of how God handles sin, including how to let go of lingering guilt ... over ten long years has been waiting to release this powerful insight about forgiveness that ... serving the Lord for over twenty years, and he has been preaching and teaching the ...
Breaking Medicine News(10 mins):